1. 2019 Annual Global Virtual Cancer Conference

    Please join us and our partner, GRYT Health, for the 2019 Annual Global Virtual Cancer Conference. Be sure to check out our LLS session, ‘Slaying Blood Cancer, One Clinical Trial at a Time’ by Laura Romundstad, RN, The Leukemia & Lymphoma Society Web address: http://www.gvcc19.com/ Live: 24 hours a day, ending December 5, 2019 Location: Wherever you’re most comfortable What’s needed: Your laptop, desktop computer or tablet Price: 100% FREE LLS session: ‘Slaying...

    Read More
  1. Harnessing the Power of Women

    “Women have the power and when we join together, we can make all the difference.” With those words, Stephanie McMahon, Chief Brand Officer at WWE, captured the theme of The Leukemia & Lymphoma Society’s (LLS) “Women Curing Cancer” initiative, which brings together philanthropic women to move collectively the needle in cancer cures and access to treatments. On Wednesday, Stephanie joined LLS’s Chief Medical Officer Dr. Gwen Nichols, and LLS volunteer Julie Guil...

    Read More
  2. Sailing In One Direction to End Childhood Cancer

    In the treatment of children with acute myeloid leukemia “We have plateaued. The tools in our toolbox are all sledgehammers.” This grim assessment was how Dr. E. Anders Kolb, of Nemours/Alfred I DuPont Hospital for Children, characterized the state of treatment for children with this devastating form of leukemia. Dr. Kolb was among a group of pediatric oncologists to join The Leukemia & Lymphoma Society (LLS) in hosting an event in Atlanta this week to discuss LLS’s new $5...

    Read More
  3. Families Fighting for Cancer Cures: Generation LLS

    As an organization founded by a family for families, The Leukemia & Lymphoma Society (LLS) is celebrating 70 years of impact on generations of families, researchers and volunteers while looking to the future by redoubling its commitment to improve treatments and care for children with cancer. To accomplish its bold vision for children, LLS is launching The LLS Children’s Initiative to deliver cures and care for children by disrupting drug development for pediatric cancers and ex...

    Read More
  1. June Education Programs

    Check out our June education events and see if LLS is coming to a city near you! Beyond Blood Cancer – New Advancements and Support June 2, 2019 – Waltham, MA https://www.eiseverywhere.com/392459 Cancer Survivorship: Living Through & Beyond Blood Cancer June 5, 2019 – Vero Beach, FL https://www.eiseverywhere.com/426989 Supervivencia: Viviendo través y más allá del cáncer (Spanish program) June 11, 2019 – El Paso, TX https://www.eiseverywhere.com/451578 Update...

    Read More
  2. Raising Our Voices

    They came from California, Colorado and Arizona, North Dakota, New Hampshire, Texas, Louisiana and Minnesota, each with their own story to tell. In all, 36 volunteers representing 25 states came to Washington D.C. this week to learn how to effectively use their stories to advocate for policies to protect blood cancer patients’ access to treatment and care. For three days these patients, survivors and caregivers took part in a training session with the dedicated policy and advocacy staff...

    Read More
  3. Evolutionary Behavior in CLL: Implications for Personalized Therapy

    In recent years, there has been a rapid surge in the amount of genomic information available to researchers. This information enhances the understanding of human disease and provides the fuel needed to achieve personalized medicine. New advances in technology and in the ability to analyze massive datasets have allowed scientists to more precisely define cancer behavior, including how these diseases adapt to evade therapy. In order to survive, cancer cells undergo genetic changes in their DNA ...

    Read More
  4. Another Advance for AML

    The steady pace of progress in treating patients with acute myeloid leukemia (AML), still one of the most deadly blood cancers, continued with today’s U.S. Food & Drug Administration’s second approval of a drug called ivosidenib (Tibsovo) that works for patients with a specific subtype of AML. In another win for precision medicine, where therapies are matched to a patient’s specific genetic profile, the FDA approved ivosidenib for newly diagnosed patients 75-years-of-age and ...

    Read More
  5. May Programs

    LLS may be coming to your town! Check out the list below of our free education programs. Rocky Mountain Blood Cancer Conference May 4, 2019 – Aurora, CO http://www.etouches.com/rmbcc19 Surviving Cancer: A Multidisciplinary Approach May 4, 2019 – Augusta, GA https://tinyurl.com/y4k978gh Exploring the Role of Transplant in Blood Cancer Treatment May 6, 2019 – Bethesda, MD https://www.eiseverywhere.com/418596 Living Well with CLL: diagnosis, treatment and ...

    Read More
  6. April Calendar of Events

    Myeloma Clinical Trial Participation: The Basics April 4, 2019 – Portland, OR https://www.eiseverywhere.com/407107 Living Well with CLL: diagnosis, treatment and support April 10, 2019 – Erie, PA https://bit.ly/CLLApril10 DC Metro Blood Cancer Conference April 13, 2019 – Washington, DC www.etouches.com/dcbcc19 Treatments and Survivorship in Blood Cancer Patients April 13, 2019 – Sioux Falls, SD https://www.eiseverywhere.com/402967 New and Eme...

    Read More